NLS Insight’s goal is to assist the Nordic regions leading innovators in targeting business collaborations, partnership opportunities and investment potential.

How public private partnerships can help us reach the 17 sustainable development goals for the world

Ideon Science Park

AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study in Japanese Patients

AbbVie

AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis

AbbVie

MEDICON VALLEY HAS THE HIGHEST CONCENTRATION OF BIOTECH COMPANIES IN NORTHERN EUROPE (NORTH OF LONDON)

Medicon Valley Alliance

Biotech

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

Cobra Biologics

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017

InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2017. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com

InDex Pharmaceuticals Holding AB – Annual Report 2017

Annual General Meeting 2018

Annual General Meeting in InDex Pharmaceuticals Holding AB will be held on May 24, 2018 at 5:00 p.m. (CET) at the company´s premises, Tomtebodavägen 23a in Stockholm, Sweden. Registration for the meeting will begin at 4:30 p.m.

Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820, are hereby summoned to the Annual General Meeting on May 24, 2018 at 5:00 p.m. (CET) at the company´s premises, Tomtebodavägen 23a in Stockholm, Sweden. Registration for the meeting begins at 4:30 p.m.

AbbVie to Present at the Deutsche Bank's 43rd Annual Health Care Conference

AbbVie

NORTH CHICAGO, Ill., April 18, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Deutsche Bank's 43rd Annual Health Care Conference on Wednesday, May 9, 2018. Bill Chase, executive vice president and chief financial officer, will present at 7 a.m. Central time.

InDex Pharmaceuticals announces the agenda for its Capital Markets Day in Stockholm on April 25, 2018

April 12th, 2018 - InDex Pharmaceuticals Holding AB (publ) (”InDex”) today announced the agenda for its Capital Markets Day that will take place in Stockholm on Wednesday April 25, 2018, for investors, analysts and media.

Receives Prestigious Grant for a Second Time

Oslo Cancer Cluster

Professor Harald Stenmark is granted the European Research Council’s (ERC) Advanced Grant for his cancer research. This is the second time he receives the grant; a privilege that has only befallen two other people, professor Edvard Moser (NTNU) and professor Kenneth Hugdahl (UiB).